Chimeric antigen receptor T cell immunotherapy in colorectal cancer: primetime yet?
ANZ J Surg
.
2024 Mar 31.
doi: 10.1111/ans.18926.
Online ahead of print.
Authors
Maria Kristina Vanguardia
1
2
,
Hannah Hassum
1
,
Sara Roth
2
,
Wendy Brown
3
,
Joseph Cherng Huei Kong
1
2
Affiliations
1
Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia.
2
School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
3
Monash University and Department of General Surgery, Alfred Hospital, Melbourne, Victoria, Australia.
PMID:
38556773
DOI:
10.1111/ans.18926
No abstract available